{"id":38998,"date":"2023-11-11T00:25:25","date_gmt":"2023-11-10T23:25:25","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=38998"},"modified":"2023-11-23T13:05:24","modified_gmt":"2023-11-23T12:05:24","slug":"nova-combinacio-de-tractaments-per-combatre-el-cancer","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/nova-combinacio-de-tractaments-per-combatre-el-cancer\/","title":{"rendered":"Nova combinaci\u00f3 de tractaments per combatre el c\u00e0ncer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Un <a href=\"https:\/\/www.imim.cat\/noticies\/1201\/apunten-a-una-nova-combinacio-de-tractaments-per-combatre-el-cancer\" target=\"_blank\" rel=\"noreferrer noopener\">recent estudi <\/a>codirigit per <strong><a href=\"https:\/\/ellipse.prbb.org\/ca\/anna-bigas-hospital-del-mar-research-institute-els-tumors-copien-mecanismes-de-les-cellules-mare-per-fer-se-mes-resistents\/\" target=\"_blank\" rel=\"noreferrer noopener\">Anna Bigas<\/a> i Llu\u00eds Espinosa <\/strong>ha revelat una <strong>nova estrat\u00e8gia per combatre la proliferaci\u00f3 de tumors: combinar diferents tractaments <\/strong>existents per atacar les c\u00e8l\u00b7lules canceroses des de tres fronts i aturar aix\u00ed la seva progressi\u00f3.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L&#8217;equip ha investigat una <strong>prote\u00efna <\/strong>anomenada <strong>IKK\u03b1<\/strong>, que regula la proliferaci\u00f3 de c\u00e8l\u00b7lules tumorals i la resist\u00e8ncia a tractaments. Encara que no \u00e9s viable atacar directament aquesta prote\u00efna a causa de la seva toxicitat, els investigadors i investigadores <strong>han identificat dues vies regulades per IKK\u03b1 que poden ser inhibides per f\u00e0rmacs<\/strong>, cosa que potencialment ofereix noves opcions terap\u00e8utiques per a pacients amb c\u00e0ncer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L&#8217;estudi ha demostrat que<strong> la inhibici\u00f3 conjunta d&#8217;aquestes vies juntament amb la quimioter\u00e0pia \u00e9s m\u00e9s efectiva<\/strong> per aturar el creixement dels tumors en comparaci\u00f3 amb tractaments individuals. Aix\u00f2 pot permetre la selecci\u00f3 de combinacions de tractaments que actu\u00efn conjuntament amb la quimioter\u00e0pia per combatre el c\u00e0ncer, <strong>reduint les dosis i la toxicitat dels tractaments<\/strong>. A m\u00e9s, identificar tumors amb aquestes vies activades pot ajudar a identificar els pacients que es podrien beneficiar d&#8217;aquestes noves estrat\u00e8gies terap\u00e8utiques.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tamb\u00e9 han identificat nivells d&#8217;IKK\u03b1 i una prote\u00efna anomenada factor inhibidor de la leuc\u00e8mia (LIF) com a marcadors de pron\u00f2stic en pacients amb <strong>c\u00e0ncer de c\u00f2lon i recte<\/strong>, cosa que podria tenir implicacions cl\u00edniques significatives.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El projecte ha estat una col\u00b7laboraci\u00f3 entre l&#8217;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.imim.es\/es_index.html\" target=\"_blank\">Hospital del Mar Research Institute<\/a>, l&#8217;Institut d&#8217;Oncologia de la Vall d&#8217;Hebron (VHIO), l&#8217;IDIBELL i l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, juntament amb investigadors del CIBER del C\u00e0ncer.<\/p>\n\n\n\n<div style=\"height:46px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Troben dues via implicades en la proliferaci\u00f3 de les c\u00e8l\u00b7lules tumorals i la seva resist\u00e8ncia a tractaments, que en ser inhibides conjuntament i unides a la quimioter\u00e0pia resulten m\u00e9s efectives.<\/p>\n","protected":false},"author":6,"featured_media":38908,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[312,213,757],"new-type":[35,43],"class_list":["post-38998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-cancer-ca","tag-imim","tag-tractament","new-type-noticies","new-type-recomanem"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/38998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=38998"}],"version-history":[{"count":6,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/38998\/revisions"}],"predecessor-version":[{"id":39004,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/38998\/revisions\/39004"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/38908"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=38998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=38998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=38998"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=38998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}